Doximity, Inc. (DOCS) — Analysis Summary
Doximity, Inc. (DOCS) has a market cap of $3.99B with year-over-year revenue growth of +13.1%. Net margin stands at 30.4%. The stock trades at a P/E ratio of 20.3.
Key Takeaways
- Revenue changed +13.1% year-over-year
- Net margin of 30.4%
- P/E ratio of 20.3
Compared to other companies in the SERVICES-COMPUTER PROGRAMMING SERVICES sector, DOCS posted revenue growth of +13.1% and trades at a P/E of 20.3.
Doximity, Inc. (DOCS)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
Sector
SERVICES-COMPUTER PROGRAMMING SERVICES
Employees
880
Headquarters
SAN FRANCISCO, CA
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.